Anika Therapeutics, Inc.
ANIK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,385 | -$82,667 | -$14,859 | $4,134 |
| Dep. & Amort. | $8,121 | $14,217 | $14,487 | $14,317 |
| Deferred Tax | $260 | -$6,327 | -$5,270 | -$1,766 |
| Stock-Based Comp. | $13,130 | $15,243 | $14,315 | $11,085 |
| Change in WC | -$13,092 | -$12,123 | -$11,821 | -$14,718 |
| Other Non-Cash | $53,369 | $69,869 | $7,557 | -$4,655 |
| Operating Cash Flow | $5,403 | -$1,788 | $4,409 | $8,397 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,734 | -$5,427 | -$7,486 | -$5,143 |
| Net Acquisitions | $0 | $0 | $0 | -$476 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $2,501 |
| Other Inv. Act. | -$600 | $0 | $0 | $0 |
| Investing Cash Flow | -$8,334 | -$5,427 | -$7,486 | -$3,118 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$284 | -$201 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$10,914 | -$5,000 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,815 | -$1,324 | -$4,568 | -$6,578 |
| Financing Cash Flow | -$12,729 | -$6,324 | -$4,852 | -$6,779 |
| Forex Effect | -$48 | $79 | -$130 | $69 |
| Net Chg. in Cash | -$15,708 | -$13,460 | -$8,059 | -$1,431 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72,867 | $86,327 | $94,386 | $95,817 |
| End Cash | $57,159 | $72,867 | $86,327 | $94,386 |
| Free Cash Flow | -$2,331 | -$7,215 | -$3,077 | $3,254 |